Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2005
12/22/2005WO2005120569A2 Improved therapeutic agent for inos generating illness
12/22/2005WO2005120568A1 Pharmaceutical composition comprising the anti-4-1bb antibody for treating or preventing rheumatoid arthritis
12/22/2005WO2005120567A2 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
12/22/2005WO2005120557A2 Inhibition of macrophage-stimulating protein receptor (ron)
12/22/2005WO2005120437A2 Method for treating lupus
12/22/2005WO2005120231A1 Connective tissue growth factor regulates intracellular signaling pathways
12/22/2005WO2005120166A2 Antibodies for selective apoptosis of cells
12/22/2005WO2005097831A3 Uses of isolated binding members capable of binding specifically to secretagogues
12/22/2005WO2005097830A3 Uses of isolated binding members capable of reducing the biological activity of secretagogue compounds
12/22/2005WO2005096706A3 Antibody to 5'-deoxy-5'-methylthioadenosine and uses thereof
12/22/2005WO2005094446A3 Anti-myostatin antibodies
12/22/2005WO2005074972A3 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists
12/22/2005WO2005074645A3 Methods and compositions for modulating angiogenesis
12/22/2005WO2005070456A8 Diagnosing and treating female reproductive tract or chilhood cancer with pmsa antibodies
12/22/2005WO2005067477A3 Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
12/22/2005WO2005060368A3 Humanized anti-ccr2 antibodies and methods of use
12/22/2005WO2005051321A3 Treatment of inflammatory bowel disease through induction of indoleamine 2,3-dioxygenase
12/22/2005WO2005051289A3 Homogeneous preparations of chimeric proteins
12/22/2005WO2005047326A3 Interleukin-10 antibodies
12/22/2005WO2005042029A3 Psma formulations and uses thereof
12/22/2005WO2005037235A3 Fibroblast growth factor receptor-1 inhibitors and methods of treatment thereof
12/22/2005WO2005034737A3 Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases
12/22/2005WO2005013912A3 Anti-fcrn antibodies for treatment of auto/allo immune conditions
12/22/2005WO2004094613A3 Polyvalent protein complex
12/22/2005WO2004091379A3 Assessing neuronal damage from blood samples
12/22/2005WO2004078937A3 Vectors used to create hybrid constant regions
12/22/2005WO2004072241A3 Compositions and methods for cleaving iap
12/22/2005WO2004022706A3 Immune cell receptor ligand and immune cell receptor
12/22/2005WO2004002427A3 Methods for the treatment or prevention of obesity
12/22/2005WO2004000216A3 Anti-tenascin antibody fragments and minibodies for treatment of lymphoma
12/22/2005WO2003099205A3 Treatment of renal carcinoma using antibodies against the egfr
12/22/2005WO2003092611A3 Methods of inducing formation of functional and organized lymphatic vessels
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283851 Novel genes encoding proteins involved in proanthocyanidin synthesis
12/22/2005US20050283842 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis
12/22/2005US20050283002 Human serine protease
12/22/2005US20050282999 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
12/22/2005US20050282765 Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity
12/22/2005US20050282745 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
12/22/2005US20050282256 Adipocyte complement related protein zacrp13
12/22/2005US20050282252 for isolation of DNA encoding anti-Rh(D) antibodies; isolation of DNA encoding antibodies directed against any red blood cells antigen or other cell antigen; for typing platelets by generating phage antibodies specific for a number of clinically important platelet antigens
12/22/2005US20050282247 Recombinant single chain antibody in heterotrophic algae for pathogen control and use
12/22/2005US20050282238 High-sensitivity chemiluminescent ELISA prion detection method
12/22/2005US20050282234 Diagnosis and/or monitoring of patients with systemic lupus erythematosus by isolating reticulocytes from a blood sample, determining the level of a C4d complement pathway component on the reticulocytes, and comparing it to a control level; an elevated lovel indicates an acute inflammatory episode
12/22/2005US20050282233 Multivalent antibody materials and methods for VEGF/PDGF family of growth factors
12/22/2005US20050282230 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
12/22/2005US20050282228 Methods and compositions for activating or inhibiting vegf-d and vegf-c
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050282187 Reagents and methods useful for detecting diseases of the urinary tract
12/22/2005US20050282181 Methods for identifying functional antibodies
12/22/2005US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides
12/22/2005US20050281831 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors
12/22/2005US20050281829 Fc chimeric proteins with anti-HIV drugs
12/22/2005US20050281828 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
12/22/2005US20050281827 Trypanosome derived apoptotic factors (TAF)
12/22/2005US20050281826 Therapeutic agent for iNOS generating illness cross-references to related applications
12/22/2005US20050281825 peptide transport proteins (PepTs); has antibody-dependent cell-mediated cytotoxic (ADCC) activity; cancer
12/22/2005US20050281823 Antibodies against human IL-12
12/22/2005US20050281822 Method of administering and using VEGF inhibitors for the treatment of malignant pleural effusion
12/22/2005US20050281821 Binds to a denatured collagens but not to native triple helical forms of the collagen; antitumor agents, antimetastasis agents; monoclonal antibodies; drug screening for denatured collagen antagonists
12/22/2005US20050281818 Method for the treatment of fibrosis
12/22/2005US20050281817 Method for treating multiple sclerosis
12/22/2005US20050281815 CD40 splice variants and their uses
12/22/2005US20050281814 Combination radiation therapy and chemotherapy in conjunction with administration of growth factor receptor antibody
12/22/2005US20050281813 Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins
12/22/2005US20050281812 Antibodies to insulin-like growth factor I receptor
12/22/2005US20050281811 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents
12/22/2005US20050281810 Variants of alternative splicing
12/22/2005US20050281807 Use of C-reactive protein to treat immune complex-mediated renal disease
12/22/2005US20050281761 Methods of preventing UVB-induced skin damage
12/22/2005US20050281741 Using cyanine dyes; in situ target tumor cells
12/22/2005DE10359189B4 Verfahren und Vorrichtung zur Elektrofusionierung von Zellen Method and apparatus for Elektrofusionierung of cells
12/22/2005DE10344545B4 Genetisch modifiziertes Kapsidprotein des Beak and Feather Disease Virus Genetically modified capsid protein of the Beak and Feather Disease Virus
12/22/2005CA2573430A1 Anti-perp antibody
12/22/2005CA2570458A1 Antibodies for selective apoptosis of cells
12/22/2005CA2570050A1 Heart and skeletal muscle inflammation (hsmi) virus
12/22/2005CA2570043A1 Env polypeptide complexes and methods of use
12/22/2005CA2569821A1 Process for protein isolation
12/22/2005CA2569788A1 Tumor specific antibody
12/22/2005CA2569692A1 Transferrin receptor antibodies
12/22/2005CA2569662A1 Heparin binding peptide
12/22/2005CA2569215A1 Screening method using antibody heavy chains
12/22/2005CA2568336A1 Method for treating lupus
12/22/2005CA2567877A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005CA2567477A1 Combination of radio waves and pharmacologically active substances
12/22/2005CA2567081A1 Anti-il-13 antibodies, crystals of anti-il-13 antibodies and complexes comprising them
12/22/2005CA2566651A1 Improved therapeutic agent for inos generating illness
12/22/2005CA2566647A1 Inhibition of macrophage-stimulating protein receptor (ron)
12/22/2005CA2565294A1 Identification of antibody-producing cells
12/22/2005CA2560759A1 Human anthrax toxin neutralizing monoclonal antibodies and methods of use thereof
12/21/2005EP1607745A2 Ligand for G-protein coupled receptor FPRL2 and uses thereof
12/21/2005EP1607404A1 Monoclonal antibody and hybridoma producing the same
12/21/2005EP1607402A1 Method for the diagnosis of tumour
12/21/2005EP1607103A1 Concomitant drug as therapeutic agent for inflammatory bowel disease
12/21/2005EP1607100A1 Remedy for spinal injury containing interleukin-6 antagonist
12/21/2005EP1606409A2 Nogo receptor binding protein
12/21/2005EP1606408A2 Human p53 splice variant displaying differential transcriptional activity
12/21/2005EP1606403A2 Hemipteran glutamate decarboxylase
12/21/2005EP1606402A1 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies
1 ... 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 ... 1494